Name: Conrado M. Fernández Rodríguez                          CURRENT POSITION Head of Gastroenterology Unit, Hospital Universitario Fundacion Alcorcón, Madrid.  Associate Professor of Medicine, University King Juan Carlos, Madrid, Spain.   ACADEMIC AND PROFESSIONAL DATA  Graduation in Medicine Universidad Autónoma de Madrid. 1981. Gastroenterology Board: 1986 “Educational Commission for Foreign Medical Graduates 1.982 (ECFMG)” (Philadelphia. USA). "Visa Qualifying Examination"(VQE) 1.983 (Philadelphia. USA). PhD in Hepatology 1992,University of Navarra, Spain Main Area of Interest: Gastroenterology and Hepatology Hirsch Index of Publications: 30   MOST RELEVANT CLINICAL TRIALS PARTICIPATION IN THE LAST 5 YEARS.   A Phase 3 safety and Efficacy Study of Boceprevir in Subjects with Chronic hepatitis C Genotype 1 who Failed Prior Treatment with Peginterferon/Ribavirin (Protocol P05101) PI of FAST-4 Predictive Factors and Assessment for the cure of the HCV in Spanish Real Clinical Practice. PI of DARGEN-3: High dose of ribavirin vs standard dose of ribavirin in patients with HCV genotype 3 and high viral load without RVR. PI of APREVIR. Assesment of Prevention of Cirrhosis Complications and Virological Response. Coordinador del estudio multicentrico APREVIR. Assesment of Prevention of Cirrhosis Complications and Virological Response. PI in the Hospital Universitario Fundación Alcorcón of the trial SPACE: A Phase II randomized, double-blind, placebo-controlled study of sorafenib or placebo in combination with transarterial chemoebolization (TACE) performed with drug-eluting beads and doxorubicin for intermediate stage hepatocellular carcinoma (HCC). PI in the Hospital Universitario Fundación Alcorcón: A Phase 3, Safety and Efficacy Study of Short Duration Boceprevir/Peg/riba in Chronic HCV Genotype 1 IL28B CC Patients (Protocol No. P07755) PI in the Hospital Universitario Fundación Alcorcón: A Phase 3 Evaluation of BMS-790052 (Daclatasvir) Compared with Telaprevir in Combination with Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Patients with Chronic Hepatitis-C PI in the Hospital Universitario Fundación Alcorcón II:A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection (PEARL-I) PI in the Hospital Universitario Fundación Alcorcón NCT01704755: A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis (Turquoise-II) PI in the Hospital Universitario Fundación Alcorcón: Phase III Hallmark QUAD: Asunaprevir+Daclatasvir+OPPeginterferon alpha-2A+ Ribavirin in previous null/partial responders. Phase I/II multicenter, randomized controlled trial to assess pharmacokinetics, pharmacodynamics safety and tolerance of Interferon Alfa 5, t.i.w. over 29 days in patients with chronic hepatitis C genotype 1. Phase IV MK-3034-040. Efficacy of 20 Wks of Boceprevir in CCIL28B genotype patients. Protocol N° GFT505-212-7. A Pivotal Study to Evaluate the Efficacy and Safety of GFT505 80 mg and GFT505 160mg on Steatohepatitis in Patients with Non-Alcoholic Steatohepatitis (NASH). A Multicentre, Randomised, Double Blind, Placebo-Controlled study 11. A randomized , Open Label Study to evaluate the safety and efficacy of coadministration of ABT-450 with ritonavir (ABT-450-r) and ABT-267 in adults with chronic hepatitis C Virus infection (Pearl-I) PI in the Hospital Universitario Fundación Alcorcón A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir and Sofosbuvir/Velpatasvir and Ribavirin in Subjects with Chronic Genotype 3 HCV Infection and Cirrhosis   Member of Association for the Study of Liver (EASL) Member of the Editorial Board Review of World Journal of Gastrointestinal Pharmacology 2009-2016. Member of the Editorial Board of World Journal of Gastroenterology Member of the Editorial Board of Journal of Clinical Gastroenterology. Associate Editor BMC Gastroenterology. Reviewer of Hepatology, Liver International, Journal of Gastroenterology and Hepatology, Journal of Paediatric Gastroenterology and Nutrition Member of the Steering Committee for the Strategic Health plan of the Madrid Regional Health Authority 2012.